Drug Database
Back to search

Belgium· BE-AMP-SAM196673-00

Fragmin 18000 IU (anti-Xa)/0,72 ml

A dalteparin product containing dalteparin sodium, registered in Belgium by Pfizer. The same ATC class is registered in 13 of our 19 countries.

ATC B01AB04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedFragmin 18000 IU (anti-Xa)/0,72 mlATCB01AB04REGISTER NO.BE-AMP-SAM196673-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dalteparin sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dalteparin is registered in 13 of 19 countries.

Countries holding a registration under ATC B01AB04 (dalteparin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search dalteparin products by name

Dalteparin · ATC B01AB04

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Dalteparin Sodium
Manufacturer
Pfizer
Country
Belgium (BE)
ATC code
B01AB04
ATC class
Dalteparin
Defined daily dose
2.5 TSD, E
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    1486182

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

203 interactions on record for dalteparin.

Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dalteparin against other medicinesHow interaction checks work

Dalteparin · interactions on record

203 records

  • 106 severe
  • 73 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe

24 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dalteparin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dalteparin products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Fragmin
  • Germany · Fragmin, Fragmin D
  • Denmark · Fragmin
  • Spain · Fragmin
  • Finland · Fragmin
  • France · Fragmine
  • United Kingdom (Northern Ireland) · Fragmin, Fragmin Graduated Syringe
  • Croatia · Fragmin
  • Iceland · Fragmin
  • Netherlands · Fragmin
  • Norway · Fragmin
  • Poland · Fragmin
  • Romania · Fragmin
  • Sweden · Fragmin
  • Slovenia · Fragmin
  • Slovakia · Fragmin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/250aa251-af72-487e-9a38-df6cb016dca5
GET /v1/drugs/250aa251-af72-487e-9a38-df6cb016dca5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Fragmin 18000 IU (anti-Xa)/0,72 ml",
  "name_fr": "Fragmin 18000 IU (anti-Xa)/0,72 ml",
  "name_nl": "Fragmin 18000 IU (anti-Xa)/0,72 ml",
  "amp_code": "SAM196673-00",
  "strengths": [
    "1000.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Dalteparin Sodium",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Dalteparin",
  "authorisation_numbers": [
    "BE196673"
  ]
}
API referenceMCP serverPlans

See everything about dalteparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console